Obinutuzumab news

All news on Obinutuzumab (also known as Gazyva and Gazyvaro): plants, production capacities, investments and involved companies.

17 October 2025
Roche's Gazyva/Gazyvaro Gains EU CHMP Nod for Lupus Nephritis
CHMP backs Gazyva/Gazyvaro for lupus nephritis, showing superior renal response in trials. Awaiting European Commission decision.

Who will be producing Obinutuzumab in the future?

Find out with chemXplore Analytics